Chemomab Therapeutics (CMMB)
(Delayed Data from NSDQ)
$0.67 USD
+0.03 (3.92%)
Updated Apr 29, 2024 12:09 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Chemomab Therapeutics Ltd. Sponsored ADR [CMMB]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
PSC Ph 2 Enrollment Completes Early Accelerating Top-line Results to Mid-Year
Provider: Roth Capital Partners, Inc.
Analyst: WHITE J
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Resuming Coverage with a Buy and $7 PT
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Biotechnology -Healthcare Coverage Update
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
|